Related Experiment Video
Updated: Jun 10, 2025

14:03
High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
1.8K
Suspected hepatotoxicity from etonogestrel contraceptive implant: A rare case report
Taylore King1, Eric Caliendo2, Ericka Scott1
1Emory University School of Medicine, Department of Gynecology and Obstetrics, Atlanta, GA, USA.
Contraception
|October 19, 2024
Abstract:
We present a case of suspected hepatotoxicity secondary to an etonogestrel contraceptive implant in which the patient presented with vomiting, jaundice, pruritis, elevated transaminases, and hyperbilirubinemia. An extensive work-up, including liver biopsy, was unremarkable. The implant was removed and the patient's symptoms and transaminitis resolved, suggestive of drug-induced liver injury.

